← Evidence map

ArticleJAAD case reports2024

Anifrolumab for the treatment of refractory chilblain lupus erythematosus.

Michael J Woodbury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38778891